Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001012975-13-000531
Filing Date
2013-11-21
Accepted
2013-11-21 20:57:18
Documents
1
Period of Report
2013-11-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3039
  Complete submission text file 0001012975-13-000531.txt   4472
Mailing Address C/O NEW LEAF VENTURE PARTNERS 2500 SAND HILL ROAD, SUITE 203 MENLO PARK CA 94025
Business Address
Lathi Vijay K (Reporting) CIK: 0001340806 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36200 | Film No.: 131236646

Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Issuer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances